Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK reviewing breast screening programme

This article was originally published in Clinica

Executive Summary

Two UK pilot studies are being set up to evaluate the effectiveness of extending the national breast screening programme to women aged 65 to 69. Junior Health Minister Baroness Cumberlege says further research was recommended by the independent advisory committee on breast cancer screening before women up to 69 were included in the scheme. The current age limits are 50-64. Preparatory work is under way for the pilot studies in South Thames and the Northern & Yorkshire regions.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT093872

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel